ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Lipocine Announces Completion of Enrollment in its Oral Testosterone Study
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 7665" data-attributes="member: 3"><p>This product is already approved in Canada and other countries. It is a safe oral testosterone undecanoate but it has a short life, so it has to be taken 3 times a day. I am not sure who would be willing to take a pill that frequently when we now have some many options that can be taken once a day (gels), once a week (T enanthate and cypionate), once every two months (T pellets or T undecanoate injections).</p><p><a href="http://www.globenewswire.com/newsroom/ctr?d=10078738&l=2&a=Lipocine%20Inc.&u=http%3A%2F%2Fwww.lipocine.com%2F" target="_blank"></a></p><p><a href="http://www.globenewswire.com/newsroom/ctr?d=10078738&l=2&a=Lipocine%20Inc.&u=http%3A%2F%2Fwww.lipocine.com%2F" target="_blank"></a></p><p><a href="http://www.globenewswire.com/newsroom/ctr?d=10078738&l=2&a=Lipocine%20Inc.&u=http%3A%2F%2Fwww.lipocine.com%2F" target="_blank">Lipocine Inc.</a> a specialty pharmaceutical company, today announced that the Company has completed enrollment of its Study of Oral Androgen Replacement ("SOAR") pivotal Phase 3 clinical study ( <a href="http://www.globenewswire.com/newsroom/ctr?d=10078738&l=2&u=http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT02081300" target="_blank">http://clinicaltrials.gov/show/NCT02081300</a> ). The trial is designed to evaluate the safety and efficacy of LPCN 1021, oral testosterone undecanoate ("TU"), in hypogonadal men with low testosterone ("Low T"). The Company expects top-line efficacy data for the trial to be available in the third quarter of 2014, with a New Drug Application ("NDA") filing with the U.S. FDA anticipated in the second half of 2015.</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 7665, member: 3"] This product is already approved in Canada and other countries. It is a safe oral testosterone undecanoate but it has a short life, so it has to be taken 3 times a day. I am not sure who would be willing to take a pill that frequently when we now have some many options that can be taken once a day (gels), once a week (T enanthate and cypionate), once every two months (T pellets or T undecanoate injections). [URL="http://www.globenewswire.com/newsroom/ctr?d=10078738&l=2&a=Lipocine%20Inc.&u=http%3A%2F%2Fwww.lipocine.com%2F"] Lipocine Inc.[/URL] a specialty pharmaceutical company, today announced that the Company has completed enrollment of its Study of Oral Androgen Replacement ("SOAR") pivotal Phase 3 clinical study ( [URL="http://www.globenewswire.com/newsroom/ctr?d=10078738&l=2&u=http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT02081300"]http://clinicaltrials.gov/show/NCT02081300[/URL] ). The trial is designed to evaluate the safety and efficacy of LPCN 1021, oral testosterone undecanoate ("TU"), in hypogonadal men with low testosterone ("Low T"). The Company expects top-line efficacy data for the trial to be available in the third quarter of 2014, with a New Drug Application ("NDA") filing with the U.S. FDA anticipated in the second half of 2015. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Lipocine Announces Completion of Enrollment in its Oral Testosterone Study
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top